GlassScriptPhysician profile
Alyssa Panagos
NPI 1174146724
$4,973.97
in general payments reported to CMS, 2019-2025
17 companies · $745 in 2025
The $745 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $404 · 2022: $1,723 · 2023: $1,424 · 2024: $678 · 2025: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,648 · Entertainment: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,647.63 |
| Entertainment | $199.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,850.00 | 2021-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $943.11 | 2022-2025 | Infuse, Biotrue One Day |
| Coopervision INC. | $382.58 | 2021-2025 | Myday Contact Lens, Misight Contact Lens, Onefit Contact Lens |
| Optos, INC. | $199.43 | 2024-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $188.47 | 2022-2024 | Total30, Dailies Total1 |
| Lkc Technologies, INC. | $188.47 | 2024-2025 | |
| Visionix USA, INC | $155.29 | 2022 | |
| Eyevance Pharmaceuticals LLC | $151.89 | 2021 | |
| Dompe US, INC. | $146.66 | 2022-2025 | Oxervate |
| Sight Sciences, INC. | $134.89 | 2023 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $125.32 | 2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $121.43 | 2021 | |
| Allergan, INC. | $115.24 | 2022 | |
| Horizon Therapeutics Plc | $111.84 | 2022 | |
| Topcon Healthcare, INC. | $104.32 | 2023-2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $39.63 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Carl Zeiss Meditec USA, INC. | $15.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Panagos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.